Poseida Therapeutics and Roche to focus on therapies for hematologic malignancies

Retrieved on: 2022-08-03 19:14:42

Tags for this article:

Click the tags to see associated articles and topics

Poseida Therapeutics and Roche to focus on therapies for hematologic malignancies. View article details on hiswai:

Excerpt

Poseida Therapeutics is partnering with Roche on developing allogeneic CAR-T therapies directed to hematologic malignancies.

Article found on: www.labiotech.eu